Lv1
30 积分 2025-02-19 加入
Adult minimal change nephropathy: experience of the collaborative study of glomerular disease
1天前
已关闭
The Treatment of Minimal Change Disease in Adults
1天前
已完结
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
1天前
已完结
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)
1天前
已完结
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease
1天前
已完结
皖公网安备34019202002308
